National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting, 23982 [2020-09118]
Download as PDF
<![CDATA[
23982
Federal Register / Vol. 85, No. 84 / Thursday, April 30, 2020 / Notices
D Table 5: Bio-defense Research
Priorities
D Table 6: Pediatric Cancer Priorities
D Table 7: Psychiatric Disorder Priorities
D Table 8: Neurological Disease
Priorities
D Table 9: Neonatal Research Priorities
D Table 10: Adolescent Research
Priorities
D Table 11: Hematologic Disease
Priorities
D Table 12: Endocrine Disease Priorities
and Diseases with Limited Alternative
Therapies
D Table 13: Dermatologic Disease
Priorities
D Table 14: Gastrointestinal Disease
Priorities
D Table 15: Renal Disease Priorities
D Table 16: Rheumatologic Disease
Priorities
D Table 17: Special Considerations.
Dated: April 22, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Neuroscience Review
Subcommittee, June 3, 2020, 8:30 a.m.
to June 3, 2020, 5:00 p.m., National
Institutes of Health, National Institute
on Alcohol Abuse and Alcoholism,
6700B Rockledge Drive, Rooms A, B, C,
Bethesda, MD, 20892 which was
published in the Federal Register on
October 02, 2019, 84 FR 52518.
This notice is being amended to
change the meeting location from the
National Institutes of Health; National
Institute on Alcohol Abuse and
Alcoholism; 6700B Rockledge Drive,
Rooms A, B, C, Bethesda, MD 20892 to
a telephone conference call. The
meeting is closed to the public.
Dated: April 24, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09196 Filed 4–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2020–09136 Filed 4–29–20; 8:45 am]
Dated: April 24, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2020–09117 Filed 4–29–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Epidemiology,
Prevention and Behavior Research
Review Subcommittee, June 8, 2020,
8:30 a.m. to June 8, 2020, 5:00 p.m.,
National Institutes of Health, National
Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20817 which was
published in the Federal Register on
March 27, 2020, 85 FR 17336.
This notice is being amended to
change the meeting location from the
National Institutes of Health; National
Institute on Alcohol Abuse and
Alcoholism; 6700B Rockledge Drive,
Bethesda, MD 20892 to a telephone
conference call. The meeting is closed to
the public.
jbell on DSKJLSW7X2PROD with NOTICES
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Cynthia Louise De La
Fuente, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G31, Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 24, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09118 Filed 4–29–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:56 Apr 29, 2020
Jkt 250001
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HIV/AIDS Clinical Trial
Units.
Date: May 20–21, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
National Cancer Institute; Notice of
Closed Meetings
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches into
Clinical Assay Development.
Date: June 11, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, Medical Center Drive, Room 7W242,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892, 240–276–6372, zhiqiang.zou@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Page 23982]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the
Epidemiology, Prevention and Behavior Research Review Subcommittee,
June 8, 2020, 8:30 a.m. to June 8, 2020, 5:00 p.m., National Institutes
of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B
Rockledge Drive, Bethesda, MD 20817 which was published in the Federal
Register on March 27, 2020, 85 FR 17336.
This notice is being amended to change the meeting location from
the National Institutes of Health; National Institute on Alcohol Abuse
and Alcoholism; 6700B Rockledge Drive, Bethesda, MD 20892 to a
telephone conference call. The meeting is closed to the public.
Dated: April 24, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-09118 Filed 4-29-20; 8:45 am]
BILLING CODE 4140-01-P
